FCS Press Releases

FCS clinical oncology nutritionist Rhone M. Levin, M.Ed, RDN, CSO, LDN, FAND, is the author of the nutrition chapter featured in the recently published 5th Edition of Lung Cancer Choices.

Sarah Cannon recently opened its newest drug development unit in collaboration with FCS and The University of Central Florida College of Medicine in Lake Nona, Fla.

Four FCS physicians are the authors of five cancer research studies that will be presented at European Society of Medical Oncology 2021.

A panel of medical experts recently provided the latest updates about COVID-19 and fielded questions from local residents. COVID-19: Speaking from Science, presented by Florida Cancer Specialists & Research Institute (FCS) in partnership with the Leesburg Area Chamber of Commerce, the City of Leesburg and Red Apples Media was held on Saturday, Aug. 28.

FCS continues to expand the number and scope of clinical trial opportunities available to cancer patients in the community setting.

In a recent evaluation, empirical data indicates FCS decreased emergency room visits not resulting in an admission or observation stay by 18% and decreased inpatient hospital admissions by 15% from 2017 – 2020. 

FCS in partnership with the Leesburg Chamber of Commerce, City of Leesburg and Red Apples Media, is sponsoring a panel discussion with area physicians to provide the latest information about COVID-19.

A survey conducted found that patients overwhelmingly prefer that the FCS physicians, nurses and staff members are vaccinated and wear masks to reduce the spread of COVID-19.

In response to growing concerns amidst the statewide surge of COVID-19 variants, FCS will require all physicians and team members to be fully vaccinated by October 1, 2021.

The in-house oral oncolytic pharmacy of Florida Cancer Specialists & Research Institute (FCS), known as Rx To Go, has been accredited by the National Association of Boards of Pharmacy® (NABP®) for both specialty pharmacy and digital pharmacy practice.

Medical oncologist James Reeves, MD, a member of the Florida Cancer Specialists & Research Institute (FCS) Clinical Research Team, is co-author of an abstract entitled “Abemaciclib combined with adjuvant endocrine therapy in patients with high risk early breast cancer who received neoadjuvant chemotherapy (NAC).”

Dr. Hugo Davila, who practices urology and minimally-invasive surgery with Florida Healthcare Specialists (FHS), is the lead author of a new study entitled “Evaluation of the Pubocervical Fascia with 3-Dimensional Endovaginal Ultrasonography (EVUS) and Correlation with Intraoperative Findings during Robotic Sacrocervicopexy.”

Lucio Gordan MD, President and Managing Physician of Florida Cancer Specialists & Research Institute (FCS) and Michael Diaz, MD, Assistant Managing Physician of FCS, are two of the authors of a comprehensive and detailed review on the advisability and efficiency of the current reimbursement methodology in use for Medicare Part B. 

Florida Cancer Specialists & Research Institute (FCS) physicians and senior leaders are the co-authors of 32 research studies that will be presented at the American Society of Clinical Oncology (ASCO®)  2021 Annual Meeting being held June 4 – 8, 2021.

Medical oncologist Syed Zafar MD, who practices at three Florida Cancer Specialists & Research Institute (FCS) locations in Lee County, is co-author of a new study entitled “Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.”

Julio Lautersztain, MD, medical oncologist who practices at Florida Cancer Specialists & Research Institute (FCS) locations in Tampa and Brandon, is co-author of a new study entitled “Novel mechanism of hereditary pyropoikilocytosis phenotype due to co‐inheritance of β globin and α spectrin mutations.”